Back

A step towards routine for stereotactic radioablation in refractory ventricular tachycardia - Interim analysis on short term safety of the first prospective, multi-centre, multi-platform study RAVENTA

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: From diagnostic evaluation to new treatment options for patients with ventricular arrhythmias Ablation of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Adrian Zaman

University Medical Center of Schleswig-Holstein, Kiel (Germany)

7 More presentations in this session

Presentation thumbnail
Diagnostic value of electroanatomical mapping in patients with suspected arrhythmogenic cardiomyopathy
Mr A. Villatore (Milan, IT)
Abstract Slides
Presentation thumbnail
Correlations between endocardial voltage mapping, diagnosis and genetic in patients with arrhythmogenic right ventricular cardiomyopathy
Doctor P. Maury (Toulouse, FR)
Abstract Slides
Presentation thumbnail
Prediction of programmed ventricular stimulation inducibility using machine learning in post-myocardial infarction patients at risk for sudden cardiac arrest with preserved ejection fraction >=40%
Doctor A. Xintarakou (Athens, GR)
Abstract Slides
Presentation thumbnail
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death
Doctor G. Lopes da Cunha (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Risk factors for the development of premature ventricular complex-induced cardiomyopathy: a systematic review and meta-analysis
Mr T. Serban (Basel, CH)
Abstract Slides

Access the full session

Session thumbnail
From diagnostic evaluation to new treatment options for patients with ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources